HA NGOC TUAN 4
4 · AVEO PHARMACEUTICALS INC · Filed Dec 14, 2012
Insider Transaction Report
Form 4
HA NGOC TUAN
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2012-12-12$6.61/sh+60,900$402,318→ 300,540 total - Other
Common Stock
2012-09-14+33,793→ 239,640 total - Other
Common Stock
2012-09-14−33,793→ 118,187 total(indirect: Held by GRAT) - Purchase
Common Stock
2012-12-13$6.85/sh+14,100$96,637→ 314,640 total
Footnotes (4)
- [F1]The increase of shares of directly held common stock was due to a distribution from the Tuan Ha-Ngoc 2009 GRAT to the reporting person on September 14, 2012.
- [F2]Includes 1208 shares acquired on June 30, 2012 under the AVEO Pharmaceuticals, Inc. Employee Stock Purchase Plan.
- [F3]The decrease of shares of indirectly held common stock was due to a distribution from the Tuan Ha-Ngoc 2009 GRAT to the reporting person on September 14, 2012.
- [F4]Shares are held by Gabriel Schmergel, Trustee, or his successor in trust, of the Tuan Ha-Ngoc 2009 GRAT. Mr. Schmergel is trustee of the Tuan Ha-Ngoc 2009 GRAT and he exercises sole voting and investment power over the shares held of record by such trust. Mr. Ha-Ngoc disclaims beneficial ownership over all such shares, except to the extent of his pecurniary interest therein.